We have audited the accompanying financial statements of NORRIS MEDICINES LIMITED (“the Company”], which comprise the Balance Sheet as at 31stMarch,2024, the Statement of Profit and Loss, the Cash Flow Statement for the year then ended and a summary of the significant accounting policies and other explanatory information.
Management's Responsibility for the Financial Statements
The Company's Board of Directors is responsible for the matters stated in Section 134(5) of the Companies Act, 2013(“the Act”] with respect to the preparation of these financial statements that give a true and fair view of the financial position and financial performance and cash flows of the Company in accordance with the accounting principles generally accepted in India, including the Accounting Standards specified under Section133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.
Auditor's Responsibility
Our responsibility is to express an opinion on these financial statements based on our audit.
We have taken into account the provisions of the Act, the accounting and auditing standards and matters which are required to be included in the audit report under the provisions of the Act and the Rules made there under.
We conducted our audit in accordance with the Standards on Auditing issued by the Institute of Chartered Accountants of India. Those Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and the disclosures in the financial statements. The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments; the auditor considers internal financial control relevant to the Company's preparation of
the financial statements that give a true and fair view in order to design audit procedures that are appropriate in the circumstances. An audit also includes evaluating the appropriateness of the accounting policies used and the reasonableness of the accounting estimates made by the Company's Directors, as well as evaluating the overall presentation of the financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the standalone financial statements.
Opinion
In our opinion and to the best of our information and according to the explanations given to us, the aforesaid financial statements give the information required by the Act in the manner so
requiredandgiveatrueandfairviewinconformitywiththeaccountingprinciplesgenerallyac ceptedinIndia,ofthestateofaffairs of the Company as at 31stMarch,2024, and its profit and its cash flows for the year ended on that date.
Report on Other Legal and Regulatory Requirements
1. As required by the Companies (Auditor's Report) Order,2016(“the Order”]issued by the Central Government of India in terms of sub-section (11) of section 143 of the Companies Act (hereinafter referred to as the "Order"), and on the basis of such checks of the books and records of the Company as we considered appropriate and according to the information and explanations given to us, we give in the Annexure a statement on the matters specified in paragraphs 3 and 4 of the said Order.
2. As required by Section143(3)of the Act, we report that:
(a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purpose so four audit.
(b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books.
(c) The Balance Sheet, the Statement of Profit and Loss and Cash Flow Statement dealt with by this Report are in agreement with the books of account.
(d) In our opinion, the aforesaid financial statements comply with the Accounting Standards specifiedunderSection133oftheAct, readwithRule7oftheCompanies (Accounts) Rules, 2014.
(e) On the basis of the written representations received from the directors as on 31stMarch,2024 and taken on record by the Board of Directors, none of the directors is disqualified as on 31st March, 2023 from being appointed as a director in terms of Section164(2) of the Act.
The Company has, in all material respects, an adequate internal financial controls
(a) system over financial reporting and such internal financial control over financial reporting were operating effectively as at 31stMarch,2024, based on the internal control over financial reporting criteria established by the Company.
(b) The reporting under Rule 11(g) of Companies (Audit and Auditors) Rules,2014 is
applicable from 1st April, 2023. Based on our examination which includes test check, the company has used an accounting software for maintaining its books of accounts which does not have a feature of recording Audit Trial (Edit Log) facility. Consequently, the company has not operated an Audit Trial for all the transactions recorded in the software throughout the year and because of that, we cannot comment that at any instance the Audit Trial feature being tampered with.
(c) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, in our opinion and to the best of our information and according to the explanations given to us:
(i) The Company has disclosed the impact, if any, of pending litigations as at 31st March, 2024on ifinancial position in its financial statements.
(ii) The Company did not have any long term term contracts including derivative contracts as at 31stMarch, 2024.
(iii) There were no amounts which were required to be transferred to the Investor Education and Protection Fund by the Company.
Place :ANKLESHWAR For, BAHEDIA & ASSOCIATES,
Date :16th August,2024 Chartered Accountants
SF-68 &69, Hexzone Arcade, 2ndFloor,
NR. Jayaben Modi Hospital, SD/-
Valia Road, GIDC, ANKLESHWAR -393002. (CA. BADRILAL R. BAHEDIA)
PROPRIETOR
M.No.048066
(Firm Reg.No.114421W)
UDIN:24048066BKADJW4386
|